RECCE PHARMACEUTICALS LTD — Capital/Financing Update 2024

Jun 30, 2024

Market Announcement

==> picture [33 x 50] intentionally omitted <==

1 July 2024

==> picture [451 x 5] intentionally omitted <==

Recce Pharmaceuticals Ltd (ASX: RCE) – Trading Halt

Description

The securities of Recce Pharmaceuticals Ltd (‘RCE’) will be placed in trading halt at the request of RCE, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 3 July 2024 or when the announcement is released to the market.

Issued by

ASX Compliance

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

1 July 2024 ASX Limited

==> picture [107 x 93] intentionally omitted <==

1 July 2024

Barbara Lim Adviser, Listing Compliance (Perth) Level 40 Central Park 152 - 158 St Georges Terrace Perth WA 6000

By email: tradinghaltsperth@asx.com.au

Dear Barbara,

Recce Pharmaceuticals Ltd (ASX:RCE) – Trading halt request

Pursuant to ASX Listing Rule 17.1, Recce Pharmaceuticals Ltd ( Company ) requests a trading halt of the Company’s securities pending the release of an announcement relating to a proposed equity capital raising.

The Company requests that the trading halt be effective immediately and remain in place until the earlier of the commencement of normal trading on Wednesday, 3 July 2024 or the release of an announcement by the Company in relation to a capital raising.

The Company is not aware of any reason why the trading halt should not be granted nor any other information necessary to inform the market about the trading halt.

This announcement has been approved for release by Recce Pharmaceuticals Board.

For further information, please contact:

Maggie Niewidok

Company Secretary

==> picture [509 x 48] intentionally omitted <==